A Rare yet Morbid Complication of Cocaine Use: Brugada Type 1 on Electrocardiogram.

antiarrhythmic agent brugada syndrome cocaine ecg patterns sodium channel blocker

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Apr 2022
Historique:
accepted: 19 04 2022
entrez: 23 5 2022
pubmed: 24 5 2022
medline: 24 5 2022
Statut: epublish

Résumé

Cocaine is considered a leading non-opioid cause of drug overdose in the US. It acts as a sympathomimetic and increases the amount of catecholamines, thereby increasing the risk of ventricular irritability and resultant arrhythmias. Its sodium (Na) channel blockage is the principal mechanism behind the Brugada pattern on an electrocardiogram (ECG), which is often transient but is indistinguishable from that of Brugada syndrome, the autosomal dominant channelopathy. We are presenting a case of a 32-year-old male with a history of cocaine and nicotine abuse, who sought medical attention for sudden-onset palpitations and pressure-like chest pain after having snorted an impressive amount of cocaine. His ECG depicted a classical Brugada pattern with ST-elevation with T inversion in V1; however, previous ECGs were normal without ST changes, signifying the Brugada pattern unmasked by cocaine use. Other investigations including stress tests and nuclear imaging were equivocal. His symptoms as well as the ECG pattern reverted to baseline signifying the presence of Brugada phenotype in the absence of channelopathy. Hence, as a sodium channel blocker, cocaine may unmask latent Brugada syndrome in asymptomatic patients without a family history. Recognizing Brugada syndrome on ECG is vital to avoid misdiagnosis and mistreatment of the patient with and without a genetic predisposition.

Identifiants

pubmed: 35602832
doi: 10.7759/cureus.24309
pmc: PMC9122013
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e24309

Informations de copyright

Copyright © 2022, Noori et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Clin Pharmacol. 1994 Sep;34(9):902-11
pubmed: 7983233
Curr Opin Cardiol. 2009 Jan;24(1):74-81
pubmed: 19102039
Am J Emerg Med. 1999 Jul;17(4):364-9
pubmed: 10452435
Europace. 2009 Aug;11(8):989-94
pubmed: 19482855
Am Heart J. 2001 Sep;142(3):402-10
pubmed: 11526352
Biophys J. 1984 Jul;46(1):15-27
pubmed: 6331543
Am J Ther. 2001 Jul-Aug;8(4):299-302
pubmed: 11441329
JAMA. 1984 Oct 12;252(14):1889-93
pubmed: 6471319
Circ Arrhythm Electrophysiol. 2013 Feb;6(1):91-100
pubmed: 23275262
Am J Cardiol. 2004 Jul 15;94(2):230-3
pubmed: 15246910
Circulation. 2005 Feb 8;111(5):659-70
pubmed: 15655131
N Engl J Med. 2001 Aug 2;345(5):351-8
pubmed: 11484693
Am J Cardiol. 2018 Mar 15;121(6):715-717
pubmed: 29397883
J Arrhythm. 2018 Jul 26;34(5):473-477
pubmed: 30327691
Orv Hetil. 2016 Mar 27;157(13):495-9
pubmed: 26996896
Circulation. 2008 Apr 8;117(14):1897-907
pubmed: 18347214

Auteurs

Muhammad Atif Masood Noori (MAM)

Internal Medicine, Dow University of Health Sciences, Karachi, PAK.
Internal Medicine, Rutgers Health/Trinitas Regional Medical Center, Elizabeth, USA.

Hardik Fichadiya (H)

Internal Medicine, Rutgers Health/Trinitas Regional Medical Center, Elizabeth, USA.

Shruti Jesani (S)

Internal Medicine, Rutgers Health/Trinitas Regional Medical Center, Elizabeth, USA.

Fareeha Abid (F)

Internal Medicine, Rutgers Health/Trinitas Regional Medical Center, Elizabeth, USA.

Nikhita Sachdeva (N)

Internal Medicine, St. George's University School of Medicine, Union, USA.

Hasham Saeed (H)

Internal Medicine, Rutgers Health/Trinitas Regional Medical Center, Elizabeth, USA.

Qirat Jawed (Q)

Internal Medicine, Rutgers Health/Trinitas Regional Medical Center, Elizabeth, USA.

Sherif Elkattawy (S)

Internal Medicine, Rutgers Health/Trinitas Regional Medical Center, Elizabeth, USA.

Meherwan Joshi (M)

Cardiology, Rutgers Health/Trinitas Regional Medical Center, Elizabeth, USA.

Classifications MeSH